ERBB2 and neoplasm: Both wild-type (NeuN) and activated (NeuNT) forms of Neu have been used; however, both drive rapid tumour formation as a result of the activity of a strong exogenous promoter, rather than amplification of the genomic locus, as occurs in the human disease (Jacot et al., 2013).